Maitri Enterprises Ltd
Incorporated in 1991, Maitri Enterprises Ltd trades in Pharmaceutical & Medical Goods.[1]
- Market Cap ₹ 14.4 Cr.
- Current Price ₹ 32.8
- High / Low ₹ 48.4 / 22.1
- Stock P/E 11.4
- Book Value ₹ 12.8
- Dividend Yield 0.00 %
- ROCE 15.0 %
- ROE 12.0 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
- Company is expected to give good quarter
- Debtor days have improved from 97.9 to 56.9 days.
- Company's working capital requirements have reduced from 87.9 days to 35.8 days
Cons
- Stock is trading at 2.56 times its book value
- Though the company is reporting repeated profits, it is not paying out dividend
- Company has a low return on equity of 8.72% over last 3 years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2015 (S) | Mar 2016 (S) | Mar 2017 (S) | Mar 2018 (S) | Mar 2019 (S) | Mar 2020 (S) | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.55 | 0.32 | 0.64 | 0.69 | 6.16 | 6.66 | 4.55 | 19.92 | 13.26 | 19.01 | 28.66 | 33.30 | 32.91 | |
| Sales growth | +1,733.33% | -41.82% | +100.00% | +7.81% | +792.75% | +8.12% | +337.80% | -33.43% | +43.36% | +50.76% | +16.19% | +16.21% | |
| 0.63 | 0.41 | 0.71 | 0.73 | 6.17 | 6.67 | 4.47 | 19.23 | 12.76 | 18.76 | 26.48 | 32.01 | 30.24 | |
| Operating Profit | -0.08 | -0.09 | -0.07 | -0.04 | -0.01 | -0.01 | 0.08 | 0.69 | 0.50 | 0.25 | 2.18 | 1.29 | 2.67 |
| OPM % | -14.55% | -28.12% | -10.94% | -5.80% | -0.16% | -0.15% | 1.76% | 3.46% | 3.77% | 1.32% | 7.61% | 3.87% | 8.11% |
| 0.11 | 0.11 | 0.10 | 0.10 | 0.08 | 0.27 | 0.09 | 0.06 | 0.11 | 0.13 | -1.01 | 0.42 | 0.05 | |
| Interest | 0.00 | 0.00 | 0.00 | 0.01 | 0.02 | 0.01 | 0.02 | 0.32 | 0.37 | 0.73 | 0.77 | 0.71 | 0.53 |
| Depreciation | 0.02 | 0.02 | 0.01 | 0.01 | 0.03 | 0.04 | 0.05 | 0.09 | 0.07 | 0.06 | 0.07 | 0.08 | 0.10 |
| Profit before tax | 0.01 | 0.00 | 0.02 | 0.04 | 0.02 | 0.21 | 0.10 | 0.34 | 0.17 | -0.41 | 0.33 | 0.92 | 2.09 |
| Tax % | 0.00% | 0.00% | 25.00% | 50.00% | 23.81% | 40.00% | 32.35% | 94.12% | 9.76% | 48.48% | 34.78% | ||
| 0.01 | 0.00 | 0.02 | 0.02 | 0.01 | 0.16 | 0.07 | 0.23 | 0.00 | -0.45 | 0.17 | 0.60 | 1.27 | |
| EPS in Rs | 0.02 | 0.00 | 0.11 | 0.11 | 0.05 | 0.84 | 0.37 | 0.52 | 0.00 | -1.02 | 0.39 | 1.36 | 2.88 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
(S): Standalone figures, shown where consolidated figures are not available.
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 49% |
| 3 Years: | 36% |
| TTM: | 16% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 54% |
| 3 Years: | % |
| TTM: | 1688% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 14% |
| 5 Years: | 27% |
| 3 Years: | 12% |
| 1 Year: | -16% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 6% |
| 3 Years: | 9% |
| Last Year: | 12% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2015 (S) | Mar 2016 (S) | Mar 2017 (S) | Mar 2018 (S) | Mar 2019 (S) | Mar 2020 (S) | Mar 2021 (S) | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Sep 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 4.75 | 1.90 | 1.90 | 1.90 | 1.90 | 1.90 | 4.40 | 4.40 | 4.40 | 4.40 | 4.40 | 4.40 | |
| Reserves | -2.80 | -0.14 | -0.13 | -0.10 | -0.09 | 0.07 | 0.57 | 0.57 | 0.12 | 0.30 | 0.86 | 1.24 | |
| 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.11 | 5.72 | 6.34 | 10.54 | 6.89 | 4.83 | 4.57 | ||
| 0.18 | 0.11 | 0.40 | 0.26 | 3.28 | 2.59 | 6.85 | 7.09 | 6.61 | 4.77 | 4.55 | 5.16 | ||
| Total Liabilities | 2.13 | 1.87 | 2.17 | 2.06 | 5.09 | 4.67 | 17.54 | 18.40 | 21.67 | 16.36 | 14.64 | 15.37 | |
| 0.09 | 0.08 | 0.06 | 0.06 | 0.13 | 0.10 | 0.28 | 0.24 | 0.24 | 0.24 | 0.39 | 0.38 | ||
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.27 | 0.27 | 3.92 | 3.74 | 3.74 | 3.74 | |
| 2.04 | 1.79 | 2.11 | 2.00 | 4.96 | 4.57 | 16.99 | 17.89 | 17.51 | 12.38 | 10.51 | 11.25 | ||
| Total Assets | 2.13 | 1.87 | 2.17 | 2.06 | 5.09 | 4.67 | 17.54 | 18.40 | 21.67 | 16.36 | 14.64 | 15.37 |
(S): Standalone figures, shown where consolidated figures are not available.
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2015 (S) | Mar 2016 (S) | Mar 2017 (S) | Mar 2018 (S) | Mar 2019 (S) | Mar 2020 (S) | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.02 | -0.22 | 0.00 | 0.17 | 0.64 | -0.39 | 0.02 | 0.06 | 3.04 | 3.09 | ||
| 0.00 | 0.00 | 0.00 | -0.01 | -0.08 | -0.62 | -3.27 | -0.24 | -3.45 | 1.23 | -0.24 | ||
| 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 | 3.69 | 0.24 | 3.49 | -4.40 | -2.76 | ||
| Net Cash Flow | 0.00 | 0.02 | -0.22 | -0.02 | 0.10 | 0.01 | 0.03 | 0.02 | 0.10 | -0.12 | 0.09 | |
| Free Cash Flow | 0.00 | 0.02 | -0.22 | -0.01 | 0.09 | 0.63 | -0.41 | -0.01 | 0.00 | 2.96 | 2.86 | |
| CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit | 0% | -33% | 300% | 0% | -1,500% | -6,900% | -41% | 38% | 92% | 148% | 250% |
(S): Standalone figures, shown where consolidated figures are not available.
Ratios
Consolidated / View Standalone
| Mar 2015 (S) | Mar 2016 (S) | Mar 2017 (S) | Mar 2018 (S) | Mar 2019 (S) | Mar 2020 (S) | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 106.18 | 433.44 | 250.94 | 333.26 | 81.77 | 60.29 | 163.81 | 205.62 | 168.00 | 68.90 | 56.89 | |
| Inventory Days | 419.75 | 580.68 | 423.07 | 304.17 | 123.56 | 132.35 | 210.48 | 261.85 | 149.78 | 102.88 | 68.38 | |
| Days Payable | 155.12 | 182.50 | 331.82 | 174.90 | 203.62 | 155.50 | 186.79 | 206.97 | 122.59 | 78.10 | 66.06 | |
| Cash Conversion Cycle | 370.81 | 831.62 | 342.19 | 462.53 | 1.71 | 37.14 | 187.50 | 260.50 | 195.19 | 93.68 | 59.20 | |
| Working Capital Days | 1,101.64 | 1,882.03 | 941.02 | 893.99 | 67.55 | 44.39 | 157.40 | 247.74 | 176.07 | 51.71 | 35.84 | |
| ROCE % | 0.51% | 0.00% | 1.13% | 2.80% | 2.22% | 11.31% | 4.91% | 2.43% | 15.83% | 15.04% |
(S): Standalone figures, shown where consolidated figures are not available.
Insights
In beta| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from Sale of Products (Pharmaceutical Trading) INR Lakhs ・Standalone data |
|
|||||||||||
| Revenue from Sale of Services (Works Contract) INR Lakhs ・Standalone data |
||||||||||||
| Work In Progress Inventory INR Lakhs ・Standalone data |
||||||||||||
| Traded Goods / Finished Goods Inventory INR Lakhs ・Standalone data |
||||||||||||
| Number of Permanent Employees count ・Standalone data |
||||||||||||
| Revenue from Related Party - Gayatri Infrastructure INR Lakhs ・Standalone data |
||||||||||||
Extracted by Screener AI
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
- Newspaper Advertisement for Un-Audited Standalone and consolidated Financial Result of the Company for the Quarter and half year ended on September 30, 2026.
- Result-Financial Result For 30Th September, 2026
-
Board Meeting Outcome for Outcome Of The Meeting Of The Board Under Regulation 30 And Submission Of Financial Results Under Regulation 33 Of The SEBI (LODR) Regulations, 2015
- Board approved unaudited Q2 FY2026-27 standalone and consolidated results on 5 Nov 2026.
-
Board Meeting Intimation for Intimation Of 5Th Board Meeting Of FY 2026-27 Under Regulation 29 Of SEBI (LODR) Regulations, 2015.
- Board meeting on November 5, 2026 to approve Q2 FY27 unaudited results; trading window closed from October 1.
-
General Announcement- Giving Of Guarantees Or Indemnity Or Becoming A Surety For Any Third Party
- Company issued Rs 40 crore corporate guarantee for Gayatri Infrastructure’s Bank of India facility.
Annual reports
-
Annual Report 2026
from bse
-
Annual Report 2025
from bse
-
Annual Report 2024
from bse
-
Annual Report 2023
from bse
-
Annual Report 2022
from bse
-
Annual Report 2021
from bse
-
Annual Report 2020
from bse
-
Annual Report 2019
from bse
-
Annual Report 2018
from bse
-
Annual Report 2017
from bse
-
Annual Report 2016
from bse
-
Annual Report 2015
from bse
-
Annual Report 2014
from bse
-
Annual Report 2013
from bse
-
Annual Report 2012
from bse
Business Overview:[1][2]
MEL is engaged in trading of Pharmaceutical & Medical Goods in Gujarat. This includes sale of service by way of works contract. Apart from this, the co. is also in the business of Infra
structure and Real Estate.